Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Body

Showing results (81-90 of 213) with videos related to

Pageof 22
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 12, 2012
Non-malignant causes of hypercalcemia in cancer patients: a frequent and neglected occurrenceM S Soyfoo, K Brenner, M Paesmans, et al.
Cancer Letters|June 10, 1998
Production and regulation of interleukin-11 by breast cancer cellsM Lacroix, B Siwek, P J Marie, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1992
Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemiaJ J Body, J C Dumon, F Seraj, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1995
Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response studyJ J Body, J C Dumon, M Piccart, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Value of CEA determination in biological fluids and tissuesJ P Sculier, J J Body, D Jacobowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonateJ J Body, A Borkowski, A Cleeren, et al.
European Journal of Cancer Care|August 3, 2006
Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial resultsJ J Body, I J Diel, D Tripathy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patientsJ J Body, J C Dumon, D Blocklet, et al.
Calcified Tissue International|April 1, 1990
Calcitonin and bone mass status in congenital hypothyroidismN Demeester-Mirkine, P Bergmann, J J Body, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1993
Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapyJ J Body, J C Dumon, M Thirion, et al.
Pageof 22

Showing results (81-90 of 213) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 12, 2012
Non-malignant causes of hypercalcemia in cancer patients: a frequent and neglected occurrenceM S Soyfoo, K Brenner, M Paesmans, et al.
Cancer Letters|June 10, 1998
Production and regulation of interleukin-11 by breast cancer cellsM Lacroix, B Siwek, P J Marie, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1992
Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemiaJ J Body, J C Dumon, F Seraj, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1995
Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response studyJ J Body, J C Dumon, M Piccart, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Value of CEA determination in biological fluids and tissuesJ P Sculier, J J Body, D Jacobowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonateJ J Body, A Borkowski, A Cleeren, et al.
European Journal of Cancer Care|August 3, 2006
Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial resultsJ J Body, I J Diel, D Tripathy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patientsJ J Body, J C Dumon, D Blocklet, et al.
Calcified Tissue International|April 1, 1990
Calcitonin and bone mass status in congenital hypothyroidismN Demeester-Mirkine, P Bergmann, J J Body, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1993
Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapyJ J Body, J C Dumon, M Thirion, et al.
Pageof 22